The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.

Bibliographic Details
Title: The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.
Authors: Bai R; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China.; Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China., Li Y; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China.; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China., Jian L; Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China., Yang Y; Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China., Zhao L; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China. lzhao@cmu.edu.cn.; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China. lzhao@cmu.edu.cn., Wei M; Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110122, People's Republic of China. mjwei@cmu.edu.cn.; Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang, 110122, People's Republic of China. mjwei@cmu.edu.cn.; Shenyang Kangwei Medical Laboratory Analysis Co. LTD, Shenyang, 110000, People's Republic of China. mjwei@cmu.edu.cn.
Source: Molecular cancer [Mol Cancer] 2022 Sep 08; Vol. 21 (1), pp. 177. Date of Electronic Publication: 2022 Sep 08.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Complete
Full text is not displayed to guests.
Description
ISSN:1476-4598
DOI:10.1186/s12943-022-01645-2